James Paul Rickey, See Remarks at ALPINE IMMUNE SCIENCES, INC. (ALPN), sold 141,204 shares at $16.06 ($2.3M) on 2023-12-04, disclosed to the SEC on 2023-12-06.
Scheduled sale ($2.3M) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.06 | 63,947 | $1.0M | 45.3% |
| 2 | $16.06 | 63,947 | $1.0M | 45.3% |
| 3 | $16.01 | 418 | $7K | 0.3% |
| 4 | $16.08 | 6,446 | $104K | 4.6% |
| 5 | $16.08 | 6,446 | $104K | 4.6% |
| Total | $16.06 avg | 141,204 |
| $2.3M |
| 100% |
| Filing → |
| ALPN | SELL | 2023-12-21 | $584K | — | Filing → |
| ALPN | SELL | 2023-12-18 | $2.0M | — | Filing → |
| ALPN | SELL | 2023-12-01 | $11K | — | Filing → |